Sectra AB header image

Sectra AB

SECT B

Equity

ISIN SE0022419784 / Valor 138742727

NASDAQ Nordic Exchange Stockholm, Equities (2026-05-28)
SEK 271.00-1.53%

Sectra AB
UMushroom community rating:

star star star star star
0.00 0 votes No rating yet
NegativeNeutralPositive

About company

Sectra AB is a Swedish company specializing in medical IT and cybersecurity solutions. With approximately 1,100 employees globally, the company focuses on developing and selling advanced technologies that cater to niche markets within these sectors. In the medical IT domain, Sectra provides systems that enhance the efficiency and effectiveness of healthcare services, such as picture archiving and communication systems (PACS) and other radiology and pathology solutions. In cybersecurity, Sectra offers secure communication systems and services designed to protect sensitive information for government and defense organizations. The company's commitment to innovation and specialized expertise positions it as a key player in both the healthcare and cybersecurity industries.

Summarized from source with an LLMView SourceSector: Technology

Latest Results (16.05.2026):

Sectra AB — Fourth quarter (Feb–Apr) 2025 and full-year 2024/2025: Sectra reported a year of solid growth driven by record order bookings and strong recurring revenue, while net sales grew modestly and profitability improved on an underlying basis. The company also proposed an ordinary and an extraordinary dividend and highlighted ongoing transition to service deliveries (cloud/recurring revenue) that will weigh on short‑term license sales but is expected to be beneficial long term.

Full‑year sales and recurring revenue

For fiscal year 2024/2025 net sales rose 9.3% to SEK 3,239.8m (SEK 2,963.6m). Recurring revenue increased 19.9% to SEK 2,067.4m and cloud recurring revenue (CRR) rose 48.9% to SEK 591.1m, showing the continued shift toward service and cloud deliveries.

Order bookings and backlog

Contracted order bookings for the year surged 39.9% to SEK 8,706.1m (6,223.5), of which SEK 7,653.0m related to guaranteed order bookings. In Q4 contracted order bookings jumped 223.4% to SEK 2,900.3m (896.9); SEK 2,382.1m of these were guaranteed, but only ~7% was recognized as revenue in the quarter and a further 15–25% is expected to be revenue within 12 months.

Profitability and cash

Operating profit for the year was SEK 723.0m, which includes SEK 110.0m from a patent settlement. Comparable operating profit (underlying operations) rose 18.4% to SEK 613.0m, giving an operating margin of 18.9% (17.5). Profit for the year was SEK 563.4m. Cash flow from operations strengthened to SEK 922.4m (326.3).

Q4 performance

In Q4 (Feb–Apr 2025) net sales were SEK 914.1m, up 1.8% (4.9% at unadjusted FX). Recurring revenue in the quarter grew 24.0% to SEK 574.6m and CRR rose 61.8% to SEK 184.1m. Q4 operating profit was SEK 198.9m (margin 21.8%) and profit for the period was SEK 131.2m (down from SEK 158.5m). Q4 cash flow from operations was SEK 222.3m (133.7).

Capital returns

The Board proposes an ordinary dividend of SEK 1.10 per share (unchanged) and an extraordinary dividend of SEK 1.00 per share, reflecting strong cash flow and the company’s financial position.

Management commentary and outlook

CEO Torbjörn Kronander highlighted record order bookings, progress in transitioning imaging to service deliveries and high customer satisfaction (Best in KLAS awards). Management warns of near‑term pressure from decreased license sales and profitability impacts as major customers go live, but expects the transition to be beneficial over the long term.

Summarized from source with an LLMView Source

Key figures

-13.7%1Y
%3Y
%5Y

Performance

31.5%1Y
31.6%3Y
31.6%5Y

Volatility

Market cap

5260 M

Market cap (USD)

Daily traded volume (Shares)

114,273

Daily traded volume (Shares)

1 day high/low

278.95 / 272.85

1 day high/low (USD)

52 weeks high/low

0.00 / 0.00

52 weeks high/low (USD)

Dividend ex-date

01 January, 2022

Dividend ex-date

Dividend

0.00

Dividend (USD)

Dividend yield (p.a.)

0.00%

Dividend yield (p.a.)

0.002022
0.002023
0.002024

Est dividend (USD)

0.00%2022
0.00%2023
0.00%2024

Est dividend yield

P/E ratio

10.00

P/E ratio

00.002022
00.002023
00.002024

Est P/E ratio

EPS

0.00

EPS (USD)

0.002022
0.002023
0.002024

Est EPS (USD)

Ratings & reviews

star star star star star

0.00

0 votes
Performance:
starstarstarstarstar
0.00
Innovation:
starstarstarstarstar
0.00
Society:
starstarstarstarstar
0.00
Nature:
starstarstarstarstar
0.00

EQUITIES OF THE SAME SECTOR

NKT A/S
NKT A/S NKT A/S Valor: 1230050
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-1.67%DKK 1,020.50
freenet AG
freenet AG freenet AG Valor: 10575025
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.86%EUR 25.42
Logitech International SA
Logitech International SA Logitech International SA Valor: 2575132
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
1.34%CHF 87.72
SFS Group Ltd
SFS Group Ltd SFS Group Ltd Valor: 23922930
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.47%CHF 126.00
Palantir Technologies Inc
Palantir Technologies Inc Palantir Technologies Inc Valor: 36244719
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
8.17%USD 156.06
PagerDuty Inc
PagerDuty Inc PagerDuty Inc Valor: 46980799
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
3.48%USD 7.44
Kura Oncology Inc
Kura Oncology Inc Kura Oncology Inc Valor: 28160920
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-2.64%USD 9.97
Soitec SA
Soitec SA Soitec SA Valor: 35180513
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
24.64%EUR 192.20
Paycom Software Inc
Paycom Software Inc Paycom Software Inc Valor: 23940068
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
3.42%USD 136.80
Jenoptik AG
Jenoptik AG Jenoptik AG Valor: 43359082
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
1.12%EUR 45.18